Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QLT Shows Off Its Assets In Hopes Of Attracting A Suitor

This article was originally published in The Pink Sheet Daily

Executive Summary

The Canadian biotech has put itself on the block after a year of changes that have transformed the company from a commercial-stage entity with pipeline assets to a one-drug tax play.

Advertisement

Related Content

QLT Gets New Lease On Life With Multi-Pronged Deals
Auxilium Accepts Endo Offer, Dumps QLT Merger Plans
Auxilium Rejects Endo, But Is It Making A Play For More Cash?
Deals Of The Week: Roche/Galaxy, Mallinckrodt/CNS Therapies, Valeant/QLT
Punctal Plug Can’t Keep QLT Afloat
Happy Return: QLT Bets Big on ForSight Plug

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS075079

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel